Dipartimento di Cardiologia, Ospedale Generale Regionale "F. Miulli, Acquaviva delle Fonti, Bari, Italy.
J Cardiovasc Electrophysiol. 2019 Aug;30(8):1281-1286. doi: 10.1111/jce.13995. Epub 2019 Jun 4.
Catheter ablation is an important treatment option for sustained ventricular arrhythmias (VA) that are refractory to pharmacological treatment; however, patients with fast VA or electrical storm (ES) are at risk for cardiogenic shock. We report our experience using cardiopulmonary support with extracorporeal membrane oxygenation (ECMO) during catheter ablation of VA.
Nineteen patients (mean age, 62 ± 10 years; 84% male) were referred to our center for CA of ES between January 2017 and April 2018. ES was defined as the occurrence of ≥3 ventricular tachycardia or ventricular fibrillation episodes requiring electrical cardioversion or defibrillation in a 24-hour period. ECMO support was implemented for all patients.
CA of ES was completed in all patients. Activation mapping was performed for all VTs and substrate modification was performed by targeting sites identified by late/fragmented abnormal potentials. VTs were not inducible after ablation in 16 of 19 patients (84%). With regard to procedural complications, two patients underwent percutaneous angioplasty with stenting for a femoral artery dissection and one patient was treated for a dislodged ECMO arterial cannula and subsequent hemorrhagic shock. After a median follow-up of 10 months, three patients died from refractory heart failure and one patient died as a result of ES. Overall, the procedural success rate was 68% and the Kaplan-Meier mortality rate was 21%.
ECMO support may be used for ablation procedures in patients with ES.
导管消融是治疗对药物治疗有抗性的持续性室性心律失常(VA)的重要治疗选择;然而,快速 VA 或电风暴(ES)的患者有发生心源性休克的风险。我们报告了在 VA 导管消融过程中使用体外膜肺氧合(ECMO)进行心肺支持的经验。
19 名患者(平均年龄 62±10 岁;84%为男性)于 2017 年 1 月至 2018 年 4 月期间因 ES 被转诊至我们中心进行 CA。ES 定义为在 24 小时内发生≥3 次需要电复律或除颤的室性心动过速或心室颤动发作。所有患者均实施 ECMO 支持。
所有患者均完成了 ES 的 CA。对所有 VT 进行了激活图描记,并通过针对晚期/碎裂异常电位确定的部位进行基质修饰。19 名患者中的 16 名(84%)在消融后 VT 不再可诱导。就程序并发症而言,2 名患者因股动脉夹层而行经皮血管成形术和支架置入,1 名患者因 ECMO 动脉插管移位和随后的失血性休克而接受治疗。在中位数为 10 个月的随访后,3 名患者死于难治性心力衰竭,1 名患者死于 ES。总的来说,程序成功率为 68%,Kaplan-Meier 死亡率为 21%。
ECMO 支持可用于 ES 患者的消融程序。